Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.4 [0.24-0.68],0.000792640579082746,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,19,0.68 [0.53-0.88],0.00317753275501218,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.13 [0.03-0.52],0.00395805192377878,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,0.33 [0.15-0.71],0.00461118397196735,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,11,1.47 [1.12-1.92],0.00522209495834433,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,0.7 [0.54-0.9],0.0053619392783373,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CES1,Liver carboxylesterase 1,Inverse variance weighted,15,0.75 [0.61-0.92],0.00669565864781034,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CNTN4,Contactin-4,Inverse variance weighted,25,1.26 [1.06-1.5],0.0103719138408518,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.8 [0.68-0.95],0.0104922407548633,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GPD1,Glycerol-3-phosphate dehydrogenase,Wald ratio,1,0.3 [0.12-0.76],0.0117647776836807,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,2.46 [1.19-5.1],0.0150769870897252,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PALM2,Paralemmin-2,Inverse variance weighted,8,0.65 [0.45-0.93],0.0182372861556213,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,UXS1,UDP-glucuronic acid decarboxylase 1,Inverse variance weighted,4,0.5 [0.28-0.9],0.0207754282552581,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSC,Dipeptidyl peptidase 1,Inverse variance weighted,28,0.86 [0.75-0.98],0.0212527963281641,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADH1B,All-trans-retinol dehydrogenase,Inverse variance weighted,3,0.69 [0.51-0.95],0.0230519752941139,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,8.92 [1.35-58.96],0.0231822176422189,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SORT1,Sortilin,Inverse variance weighted,3,0.58 [0.36-0.93],0.023319886994515,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NME3,Nucleoside diphosphate kinase 3,Inverse variance weighted,11,0.72 [0.54-0.96],0.0241248163733233,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,13,1.38 [1.03-1.85],0.0326190827991283,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.81 [0.66-0.98],0.0331848452368081,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,6,0.67 [0.46-0.98],0.0365205528239139,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.48 [1.02-2.13],0.0368598884961726,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.27 [1.01-1.59],0.0405724362486495,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TCOF1,Treacle protein,Wald ratio,1,0.16 [0.03-0.93],0.0411984261516169,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.87 [0.76-1],0.0441472037666834,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.55 [0.31-0.99],0.0458317708410644,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SGSH,N-sulphoglucosamine sulphohydrolase,Inverse variance weighted,39,1.13 [1-1.28],0.0460826723708265,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.45 [0.21-0.99],0.0461140643149426,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1.1 [1-1.21],0.0534970936091064,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.33 [1-1.77],0.0535642729286625,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FUOM,Fucose mutarotase,Inverse variance weighted,3,2.17 [0.99-4.75],0.0539937274178934,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.1 [0.01-1.1],0.0594854774510734,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,4,1.46 [0.98-2.17],0.0601159205124985,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.76 [0.57-1.01],0.0603639657058943,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,17,1.16 [0.99-1.35],0.0611569552622166,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.18 [0.99-1.41],0.0621324700340147,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ARSA,Arylsulfatase A,Inverse variance weighted,16,1.17 [0.99-1.37],0.0672689418923117,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,20,1.19 [0.99-1.44],0.0700207162011263,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,31,0.84 [0.7-1.01],0.070184203965807,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,20,0.84 [0.69-1.02],0.0721462851514275,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.85 [0.71-1.02],0.0732030134636753,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.59 [0.96-2.64],0.0736473794292767,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NFASC,Neurofascin,Inverse variance weighted,15,1.23 [0.98-1.54],0.0775768995971061,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,1.24 [0.97-1.58],0.0809488323367606,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDC4,Syndecan-4,Inverse variance weighted,8,1.42 [0.96-2.1],0.0809709321507183,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,9,1.31 [0.96-1.78],0.0844353815353237,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,2.05 [0.9-4.66],0.0878270153729794,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IDUA,Alpha-L-iduronidase,Inverse variance weighted,35,0.89 [0.78-1.02],0.0879707517614626,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PKD1,Polycystin-1,Inverse variance weighted,12,1.31 [0.96-1.79],0.0888234137697704,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TLR1,Toll-like receptor 1,Inverse variance weighted,16,0.79 [0.61-1.04],0.0917206598524444,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,1.29 [0.96-1.73],0.0926556837910505,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,XCL1,Lymphotactin,Inverse variance weighted,31,0.89 [0.78-1.02],0.0950254497122224,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.57 [0.92-2.69],0.100660191186472,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NT5E,5'-nucleotidase,Inverse variance weighted,45,0.88 [0.76-1.03],0.1010795022303,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Inverse variance weighted,12,0.82 [0.64-1.04],0.101924192214012,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,0.89 [0.78-1.02],0.104974338860828,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALCAM,CD166 antigen,Inverse variance weighted,6,1.56 [0.9-2.72],0.113913285746067,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.24 [0.95-1.63],0.116172776679294,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.09 [0.98-1.23],0.1202450118716,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.6 [0.88-2.91],0.120484847043429,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH2,Cadherin-2,Inverse variance weighted,3,2.03 [0.82-5.05],0.126136388436446,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.35 [0.92-2],0.127891651864072,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RBKS,Ribokinase,Inverse variance weighted,11,0.89 [0.77-1.03],0.131487187056925,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.84 [0.67-1.05],0.131652784863689,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.7 [0.44-1.12],0.132794076793988,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.26 [0.93-1.7],0.133790136435956,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.22 [0.94-1.6],0.14093754318889,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.33 [0.91-1.94],0.140949898693731,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,0.94 [0.86-1.02],0.14249902958283,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,1.21 [0.94-1.57],0.144194384714077,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GSR,"Glutathione reductase, mitochondrial",Wald ratio,1,0.81 [0.61-1.08],0.148901841850856,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,1.62 [0.84-3.13],0.14911427571415,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,UPB1,Beta-ureidopropionase,Inverse variance weighted,3,0.43 [0.13-1.36],0.150313620136327,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,1.14 [0.95-1.38],0.152440103821592,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,24,1.09 [0.97-1.23],0.152444051899522,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACY1,Aminoacylase-1,Inverse variance weighted,4,1.48 [0.86-2.55],0.155118040057533,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TSPAN8,Tetraspanin-8,Inverse variance weighted,25,0.86 [0.69-1.06],0.156847071688871,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,39,0.87 [0.72-1.06],0.158904818776981,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,3.16 [0.63-15.82],0.161053957444614,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGSF9,Protein turtle homolog A,Inverse variance weighted,10,0.82 [0.62-1.08],0.1626512256642,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THBS4,Thrombospondin-4,Inverse variance weighted,9,0.82 [0.61-1.09],0.167996397959982,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.8 [0.57-1.1],0.168334562990684,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.48 [0.85-2.6],0.16842263719716,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MMP7,Matrilysin,Inverse variance weighted,13,0.85 [0.67-1.07],0.171078309276817,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGA5,Integrin alpha-5,Wald ratio,1,2.82 [0.63-12.49],0.17309068879679,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FBLN2,Fibulin-2,Inverse variance weighted,11,1.18 [0.93-1.49],0.176692360240851,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDGFRB,Platelet-derived growth factor receptor beta,Inverse variance weighted,41,1.06 [0.98-1.15],0.177916145677492,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,0.89 [0.75-1.05],0.178457893998427,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL8,Interleukin-8,Inverse variance weighted,6,1.95 [0.73-5.19],0.179856468710326,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,0.79 [0.55-1.12],0.182503036375036,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.61 [0.29-1.27],0.183831569073824,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,0.86 [0.69-1.07],0.18575483793884,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.15 [0.93-1.42],0.188659006904649,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.15 [0.93-1.41],0.192981869481444,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.33 [0.86-2.06],0.193523233098353,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH1,Cadherin-1,Wald ratio,1,3.45 [0.52-23.01],0.200530558016419,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.11 [0.94-1.32],0.2046476768093,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.3 [0.87-1.94],0.206955951142421,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD48,CD48 antigen,Inverse variance weighted,18,0.88 [0.73-1.07],0.210442975503208,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,11,1.19 [0.9-1.58],0.211763224680155,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.64 [0.31-1.3],0.213271078072189,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.77 [0.5-1.17],0.217955742309932,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.69 [0.38-1.25],0.219994752453173,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCLY,Selenocysteine lyase,Inverse variance weighted,4,0.78 [0.51-1.17],0.228187791421255,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.81 [0.69-4.8],0.229823231400664,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTN,Pleiotrophin,Inverse variance weighted,4,1.56 [0.75-3.28],0.23703615247124,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,17,0.92 [0.79-1.06],0.23878249281016,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.84 [0.63-1.13],0.243781150253806,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,1.27 [0.85-1.92],0.245629263781475,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.88 [0.71-1.09],0.250790940716667,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,OCLN,Occludin,Inverse variance weighted,2,1.49 [0.75-2.94],0.251576061330836,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VCAN,Versican core protein,Inverse variance weighted,31,0.92 [0.79-1.07],0.255659228341742,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,3,0.32 [0.05-2.27],0.256150525877936,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.16 [0.9-1.5],0.258761019837873,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,1.08 [0.94-1.25],0.259187519694471,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL32,Interleukin-32,Inverse variance weighted,11,0.77 [0.49-1.21],0.261502666837535,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDK2,Protein sidekick-2,Inverse variance weighted,18,1.11 [0.93-1.32],0.263830349835738,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEZ6L,Seizure 6-like protein,Inverse variance weighted,8,1.2 [0.87-1.66],0.266003011749929,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.92 [0.8-1.07],0.271712059335506,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TLR3,Toll-like receptor 3,Inverse variance weighted,43,0.93 [0.83-1.06],0.276716460667643,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH5,Cadherin-5,Inverse variance weighted,3,0.81 [0.56-1.18],0.278064223459151,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SELE,E-selectin,Inverse variance weighted,4,0.63 [0.28-1.45],0.278067834981223,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,7,1.26 [0.83-1.9],0.278924002093165,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,1.34 [0.79-2.26],0.281044983501712,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.85 [0.63-1.14],0.2845581928781,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",Wald ratio,1,0.66 [0.31-1.42],0.284695449949579,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.24 [0.84-1.83],0.285058230444469,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GSTA1,Glutathione S-transferase A1,Inverse variance weighted,7,1.51 [0.71-3.25],0.286598807171095,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,29,1.07 [0.94-1.22],0.286660863522608,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD276,CD276 antigen,Inverse variance weighted,20,0.92 [0.8-1.07],0.288255222518408,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AGRN,Agrin,Inverse variance weighted,17,0.87 [0.67-1.13],0.289203427517699,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GOT1,"Aspartate aminotransferase, cytoplasmic",Wald ratio,1,3.25 [0.37-28.67],0.289264476289015,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,24,1.1 [0.92-1.31],0.29013927461056,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.9 [0.73-1.1],0.294657665739649,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.35 [0.77-2.35],0.296723446152349,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSL,Cathepsin L1,Wald ratio,1,2.75 [0.41-18.56],0.298448608015789,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSB,Cathepsin B,Inverse variance weighted,26,0.92 [0.79-1.08],0.298469006316194,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1.07 [0.94-1.21],0.298483515476726,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.5 [0.7-3.21],0.300978747344365,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.73 [0.4-1.33],0.304123702715669,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.42 [0.73-2.78],0.30690796881584,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,7,1.5 [0.68-3.27],0.313870798980431,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.32 [0.77-2.27],0.316137501773182,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PON2,Serum paraoxonase/arylesterase 2,Inverse variance weighted,42,0.94 [0.84-1.06],0.316932235471465,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.32 [0.77-2.27],0.317229461764304,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSS,Cathepsin S,Inverse variance weighted,23,0.92 [0.77-1.09],0.320295796997102,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.85 [0.62-1.17],0.322176129745056,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.36 [0.74-2.49],0.32460836489212,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,10,0.88 [0.68-1.14],0.326547663168777,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.12 [0.89-1.41],0.326963559656887,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,Inverse variance weighted,30,1.07 [0.94-1.22],0.327827979945672,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GZMA,Granzyme A,Inverse variance weighted,2,0.49 [0.12-2.05],0.329218092077079,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,1.55 [0.64-3.74],0.329454410175633,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,1.11 [0.9-1.37],0.333719484500274,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.39 [0.06-2.65],0.333869077247417,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ROBO2,Roundabout homolog 2,Inverse variance weighted,2,0.52 [0.14-1.95],0.333876516818241,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.89 [0.69-1.13],0.334906556208508,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,13,1.11 [0.89-1.39],0.335690942341941,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.41 [0.69-2.85],0.344562240397212,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.91 [0.76-1.1],0.347201690897219,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.12 [0.88-1.42],0.348481021585907,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.09 [0.91-1.32],0.350264977386775,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEZ6,Seizure protein 6 homolog,Inverse variance weighted,2,1.71 [0.55-5.33],0.352431975213013,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ASAH1,Acid ceramidase,Inverse variance weighted,20,0.93 [0.81-1.08],0.354822631576007,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.07 [0.93-1.24],0.355713147097001,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,Inverse variance weighted,12,1.17 [0.84-1.62],0.360045084045659,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.8 [0.5-1.29],0.360848404695008,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,8,1.42 [0.66-3.02],0.366266909346162,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,0.9 [0.7-1.14],0.371921015486947,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,APOA2,Apolipoprotein A-II,Wald ratio,1,1.82 [0.48-6.91],0.380445206706339,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLUL1,Clusterin-like protein 1,Inverse variance weighted,18,1.06 [0.93-1.22],0.381497755242026,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPON2,Spondin-2,Inverse variance weighted,4,1.18 [0.81-1.73],0.382250314198767,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSD,Cathepsin D,Inverse variance weighted,17,0.9 [0.7-1.15],0.382948400007478,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,1.04 [0.95-1.15],0.385732008703579,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,2.9 [0.26-32.63],0.389645250049126,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.57 [0.56-4.38],0.389665087409839,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,4,1.6 [0.55-4.7],0.389733763160437,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,0.85 [0.6-1.22],0.390463307555873,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,0.74 [0.38-1.46],0.390774358646899,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADA,Adenosine deaminase,Inverse variance weighted,22,0.94 [0.81-1.09],0.395391514141274,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.06 [0.92-1.23],0.397694646748253,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GGH,Gamma-glutamyl hydrolase,Inverse variance weighted,23,0.93 [0.78-1.1],0.402696541370663,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.16 [0.82-1.66],0.402720390536139,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.86 [0.61-1.22],0.404538395815172,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.65 [0.51-5.41],0.404614997260191,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BOC,Brother of CDO,Inverse variance weighted,6,0.8 [0.46-1.37],0.408689977768974,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.88 [0.64-1.2],0.414374570893505,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,2.41 [0.29-20.11],0.417328622901117,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.11 [0.86-1.43],0.423295388128941,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SERPINA9,Serpin A9,Inverse variance weighted,25,0.94 [0.81-1.09],0.426559865711915,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,4,1.25 [0.72-2.17],0.430716126490077,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENTR1,Endosome-associated-trafficking regulator 1,Inverse variance weighted,7,1.24 [0.72-2.12],0.435003258324954,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD22,B-cell receptor CD22,Inverse variance weighted,6,1.13 [0.83-1.56],0.435010022552629,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL18,Interleukin-18,Inverse variance weighted,16,0.82 [0.5-1.35],0.436453587194442,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NELL2,Protein kinase C-binding protein NELL2,Inverse variance weighted,6,0.84 [0.53-1.31],0.436705106712006,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,1.19 [0.77-1.84],0.437238476705011,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.78 [0.42-1.46],0.437355490202809,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.09 [0.88-1.35],0.437877620221647,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1.08 [0.89-1.31],0.439287404384703,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.14 [0.81-1.6],0.440700764418394,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.86 [0.58-1.26],0.4427110027839,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.79 [0.43-1.44],0.443873867164944,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.68 [0.25-1.82],0.444127365077073,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1.24 [0.71-2.17],0.444298587936441,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HEG1,Protein HEG homolog 1,Inverse variance weighted,4,1.32 [0.64-2.7],0.451663568145555,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,INSR,Insulin receptor,Wald ratio,1,0.52 [0.09-2.93],0.456028903320413,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCRL1,Fc receptor-like protein 1,Inverse variance weighted,19,0.91 [0.72-1.16],0.456987759051057,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,14,1.08 [0.88-1.32],0.458268143509769,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCRL5,Fc receptor-like protein 5,Inverse variance weighted,18,1.08 [0.88-1.34],0.459087522827146,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CR2,Complement receptor type 2,Inverse variance weighted,6,0.84 [0.54-1.33],0.459723815517555,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.96 [0.85-1.07],0.460978614490872,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TYRO3,Tyrosine-protein kinase receptor TYRO3,Inverse variance weighted,33,0.95 [0.83-1.09],0.463041731669164,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.25 [0.68-2.3],0.463748561285925,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.86 [0.58-1.29],0.466324007094172,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MUC13,Mucin-13,Inverse variance weighted,9,0.87 [0.59-1.27],0.472230931167268,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHGA,Chromogranin-A,Inverse variance weighted,3,1.18 [0.75-1.84],0.475703446056643,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDH12,Protocadherin-12,Inverse variance weighted,13,0.92 [0.74-1.15],0.47886087889129,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANPEP,Aminopeptidase N,Inverse variance weighted,23,0.94 [0.78-1.13],0.480339877029599,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.06 [0.9-1.25],0.484410117486825,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,17,0.95 [0.81-1.1],0.484595959987594,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.23 [0.69-2.17],0.484842168488967,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.83 [0.5-1.39],0.486467392055849,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD86,T-lymphocyte activation antigen CD86,Inverse variance weighted,5,0.87 [0.58-1.3],0.489040095240362,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.48 [0.06-3.99],0.495455874244141,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.77 [0.35-1.66],0.497551052953383,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SHISA5,Protein shisa-5,Inverse variance weighted,5,1.42 [0.51-3.97],0.498807734255705,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,0.82 [0.46-1.47],0.501766492910153,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,Inverse variance weighted,10,0.9 [0.66-1.22],0.502673877787116,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HMOX1,Heme oxygenase 1,Wald ratio,1,1.58 [0.41-6.04],0.504621386283292,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.83 [0.48-1.44],0.504754122845668,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,0.86 [0.56-1.33],0.506159472075144,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.13 [0.79-1.62],0.507972832707005,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDH17,Protocadherin-17,Inverse variance weighted,2,1.3 [0.59-2.85],0.509515828041889,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GUSB,Beta-glucuronidase,Inverse variance weighted,4,0.78 [0.37-1.64],0.512606290577678,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPQ,Carboxypeptidase Q,Inverse variance weighted,20,0.95 [0.82-1.1],0.512736345584296,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD83,CD83 antigen,Inverse variance weighted,5,1.19 [0.7-2.01],0.513643591279024,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.09 [0.83-1.44],0.516228550462008,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGMN,Legumain,Inverse variance weighted,12,0.92 [0.73-1.17],0.516498045014882,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH17,Cadherin-17,Inverse variance weighted,14,1.09 [0.85-1.39],0.51773108165849,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.57 [0.4-6.17],0.520104134905717,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.03 [0.94-1.14],0.521161199238749,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,14,1.1 [0.83-1.46],0.52179146257941,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CFHR5,Complement factor H-related protein 5,Inverse variance weighted,25,0.97 [0.89-1.06],0.523847940187403,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.89 [0.62-1.27],0.52431106606967,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,0.67 [0.2-2.3],0.52461882977613,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LY75,Lymphocyte antigen 75,Inverse variance weighted,59,1.03 [0.93-1.14],0.528146487956184,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.22 [0.66-2.27],0.528918466309571,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.93 [0.73-1.18],0.528965233351186,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.9 [0.65-1.25],0.531667344465213,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,2,0.65 [0.17-2.53],0.532533106856882,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EDN1,Endothelin-1,Inverse variance weighted,3,0.88 [0.6-1.31],0.537035625177713,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.93 [0.73-1.18],0.540258868224442,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PSAP,Prosaposin,Inverse variance weighted,5,1.13 [0.76-1.67],0.541533885859977,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.94 [0.78-1.14],0.545629087606858,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CALCA,Calcitonin,Inverse variance weighted,5,0.73 [0.26-2.06],0.548048791195114,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACHE,Acetylcholinesterase,Inverse variance weighted,22,1.08 [0.83-1.42],0.549566769097827,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.61 [0.34-7.75],0.551139983405715,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGB7,Integrin beta-7,Inverse variance weighted,3,0.9 [0.63-1.28],0.553425315351374,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.92 [0.7-1.21],0.556952722298751,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,10,0.92 [0.7-1.21],0.558098599401974,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,APOL1,Apolipoprotein L1,Inverse variance weighted,3,1.12 [0.77-1.62],0.558690661706078,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.77 [0.32-1.84],0.56023529294279,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGB2,Integrin beta-2,Inverse variance weighted,4,0.86 [0.53-1.42],0.561230665557994,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOMO1,Nodal modulator 1,Inverse variance weighted,2,1.18 [0.68-2.05],0.561859659764541,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,21,1.05 [0.89-1.24],0.563200641923869,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,1.03 [0.94-1.12],0.572256500201942,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,0.91 [0.65-1.27],0.576563577310896,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,9,1.09 [0.8-1.49],0.577670681975358,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGALS4,Galectin-4,Inverse variance weighted,4,0.86 [0.49-1.48],0.579002807440499,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,5,0.8 [0.37-1.75],0.579687423815174,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,4,0.89 [0.58-1.36],0.581549609939877,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.68 [0.17-2.67],0.583682592391346,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1.04 [0.91-1.19],0.58529912774282,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGALS9,Galectin-9,Inverse variance weighted,26,0.95 [0.78-1.15],0.586476967638473,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Inverse variance weighted,6,0.89 [0.59-1.35],0.587296160481258,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VWF,von Willebrand factor,Inverse variance weighted,2,1.23 [0.57-2.64],0.59360713383851,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,Inverse variance weighted,16,0.96 [0.84-1.11],0.594703739507473,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,19,0.96 [0.84-1.11],0.597724155696951,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KYNU,Kynureninase,Inverse variance weighted,8,0.88 [0.54-1.43],0.59858161315264,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DSCAM,Down syndrome cell adhesion molecule,Inverse variance weighted,11,0.96 [0.82-1.12],0.601369286351275,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.1 [0.76-1.59],0.6016139439235,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,10,1.16 [0.66-2.04],0.603206686885141,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDH9,Protocadherin-9,Inverse variance weighted,16,0.94 [0.75-1.19],0.60868873487945,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAYN,Layilin,Inverse variance weighted,20,1.08 [0.8-1.46],0.614827636084965,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,1.29 [0.47-3.53],0.61799802025379,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FRZB,Secreted frizzled-related protein 3,Inverse variance weighted,21,0.95 [0.79-1.15],0.618039911683045,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,0.9 [0.61-1.35],0.619258397698136,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.92 [0.65-1.3],0.626934005250762,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.96 [0.81-1.14],0.628976657413831,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1.08 [0.79-1.47],0.630296528751125,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.07 [0.8-1.43],0.632138468284186,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AREG,Amphiregulin,Inverse variance weighted,3,1.26 [0.48-3.33],0.637224311188969,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.94 [0.71-1.23],0.637923277480089,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.03 [0.91-1.16],0.638950476441158,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.16 [0.63-2.11],0.639223193236203,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD302,CD302 antigen,Inverse variance weighted,9,0.93 [0.69-1.25],0.639247509419632,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.67 [0.13-3.5],0.639265087051042,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.14 [0.65-1.99],0.639939801177552,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,1.06 [0.83-1.35],0.640730563247599,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.86 [0.46-1.61],0.641027215378054,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.94 [0.71-1.23],0.642735846348375,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.89 [0.54-1.47],0.644368047569382,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C7,Complement component C7,Inverse variance weighted,38,1.03 [0.92-1.15],0.645562354672888,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.02 [0.93-1.12],0.64821757957654,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GRN,Progranulin,Inverse variance weighted,7,1.07 [0.8-1.42],0.652926596416853,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PVR,Poliovirus receptor,Inverse variance weighted,27,1.03 [0.91-1.16],0.657129439448144,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,STC1,Stanniocalcin-1,Inverse variance weighted,2,0.65 [0.1-4.28],0.657234621688209,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,0.88 [0.49-1.58],0.657685703035272,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.11 [0.69-1.79],0.660754303202974,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ECE1,Endothelin-converting enzyme 1,Wald ratio,1,0.7 [0.14-3.49],0.664025764706553,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,1.06 [0.82-1.37],0.666153274988874,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.95 [0.77-1.18],0.667745944934562,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.08 [0.76-1.53],0.672355063394021,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.04 [0.85-1.28],0.672624529429921,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.08 [0.75-1.55],0.67541522698951,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.19 [0.53-2.68],0.67574608231966,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.65 [0.08-5.01],0.677919469325839,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,0.91 [0.59-1.4],0.678190868128197,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRSS8,Prostasin,Inverse variance weighted,5,1.14 [0.61-2.12],0.679961944651072,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.91 [0.59-1.42],0.680939682247893,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLEC11A,C-type lectin domain family 11 member A,Inverse variance weighted,7,0.95 [0.74-1.22],0.683224776998419,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.06 [0.79-1.43],0.684038351404806,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LEPR,Leptin receptor,Inverse variance weighted,8,1.09 [0.73-1.61],0.684111710586641,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Wald ratio,1,1.15 [0.58-2.27],0.685350401405378,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,1.21 [0.47-3.13],0.687107358162494,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.81 [0.28-2.31],0.687156591007894,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,0.87 [0.45-1.69],0.689301657520244,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,26,1.03 [0.89-1.19],0.689588736965799,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,1.09 [0.72-1.64],0.691236297986952,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,0.92 [0.62-1.38],0.691904730429822,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MVK,Mevalonate kinase,Inverse variance weighted,2,1.21 [0.47-3.14],0.692892126790941,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,1.03 [0.88-1.21],0.693654280248976,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.06 [0.8-1.4],0.695060705468746,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.1 [0.68-1.76],0.697538426949303,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MILR1,Allergin-1,Inverse variance weighted,33,1.02 [0.92-1.13],0.697671164432924,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.07 [0.75-1.53],0.698952997006234,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,1.09 [0.71-1.65],0.700201818402177,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFNGR2,Interferon gamma receptor 2,Inverse variance weighted,27,1.02 [0.92-1.13],0.703567950822965,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC9,Sialic acid-binding Ig-like lectin 9,Inverse variance weighted,23,1.05 [0.82-1.34],0.704078760656364,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,0.96 [0.75-1.21],0.704826000176897,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.02 [0.93-1.11],0.705876980300704,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MMP10,Stromelysin-2,Inverse variance weighted,22,1.04 [0.84-1.29],0.70676960203462,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.12 [0.61-2.05],0.707839804260754,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.86 [0.39-1.91],0.711549324739221,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,1.05 [0.82-1.34],0.713299946739826,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD55,Complement decay-accelerating factor,Inverse variance weighted,15,1.04 [0.85-1.26],0.71493424906322,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.95 [0.71-1.26],0.717409992946566,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.92 [0.6-1.43],0.717740079521223,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.92 [0.57-1.47],0.720321020604937,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.69 [0.09-5.17],0.72128900509149,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.1 [0.65-1.86],0.722709455408322,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.97 [0.8-1.17],0.723166768179833,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.11 [0.62-2],0.724357271554622,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.92 [0.59-1.44],0.725620602035043,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRTG,Protogenin,Inverse variance weighted,19,0.96 [0.79-1.18],0.726421909280506,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.05 [0.81-1.35],0.72647681765108,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.9 [0.49-1.64],0.726889081164413,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VSIG10,V-set and immunoglobulin domain-containing protein 10,Inverse variance weighted,26,1.03 [0.87-1.21],0.727192063988467,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.85 [0.33-2.15],0.728185782689933,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,1.05 [0.8-1.37],0.729008800739595,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD27,CD27 antigen,Inverse variance weighted,9,0.94 [0.65-1.35],0.730761840142378,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.03 [0.87-1.23],0.731149743490519,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.1 [0.62-1.95],0.738949173193582,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,0.96 [0.77-1.21],0.739380221109064,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.02 [0.89-1.18],0.740723000101906,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPVL,Probable serine carboxypeptidase CPVL,Inverse variance weighted,28,0.98 [0.84-1.13],0.747472760121887,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLIT2,Slit homolog 2 protein,Inverse variance weighted,2,0.82 [0.24-2.78],0.748426176434607,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Inverse variance weighted,22,1.04 [0.81-1.33],0.750877287373969,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SORD,Sorbitol dehydrogenase,Inverse variance weighted,3,1.08 [0.65-1.8],0.752982424524684,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,0.91 [0.52-1.61],0.753170496795244,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.97 [0.8-1.17],0.754543609237313,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,0.95 [0.68-1.32],0.759352718785192,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,0.95 [0.7-1.29],0.76259379832589,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CR1,Complement receptor type 1,Inverse variance weighted,21,0.97 [0.81-1.17],0.764444287928472,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,3,1.06 [0.71-1.59],0.765008035464891,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.92 [0.54-1.57],0.76580301292864,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,Inverse variance weighted,34,1.02 [0.88-1.18],0.767066520304279,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.14 [0.47-2.78],0.771244391244257,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NRP1,Neuropilin-1,Inverse variance weighted,12,1.04 [0.81-1.32],0.773917127832619,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.04 [0.81-1.32],0.776558206023163,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ISM1,Isthmin-1,Inverse variance weighted,10,0.96 [0.71-1.3],0.77680732775664,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENG,Endoglin,Inverse variance weighted,9,0.96 [0.71-1.29],0.780255219396787,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PODXL,Podocalyxin,Inverse variance weighted,6,1.07 [0.66-1.72],0.781710307318712,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MARCO,Macrophage receptor MARCO,Inverse variance weighted,10,0.96 [0.72-1.28],0.786896694740477,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GBP1,Guanylate-binding protein 1,Inverse variance weighted,10,1.04 [0.8-1.34],0.787188261086526,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,4,0.93 [0.52-1.65],0.795114013633562,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,0.9 [0.4-2.04],0.79680961558435,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.96 [0.7-1.32],0.797108831471135,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DDC,Aromatic-L-amino-acid decarboxylase,Inverse variance weighted,10,0.97 [0.77-1.22],0.799983368725562,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.94 [0.6-1.48],0.800497363579878,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.06 [0.66-1.72],0.800760620657089,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.97 [0.79-1.2],0.802402339971646,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MATN2,Matrilin-2,Inverse variance weighted,18,0.96 [0.72-1.29],0.802663321806026,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.94 [0.55-1.59],0.806497038179141,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRM,Receptor-type tyrosine-protein phosphatase mu,Inverse variance weighted,6,1.09 [0.55-2.15],0.806575933295531,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1.02 [0.88-1.17],0.809017776960737,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,1.04 [0.76-1.42],0.809980940470336,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.07 [0.63-1.8],0.811457417926153,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.02 [0.88-1.17],0.812262441606356,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,0.98 [0.81-1.17],0.81572288591227,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.95 [0.63-1.45],0.816067514415333,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDC1,Syndecan-1,Inverse variance weighted,2,0.93 [0.49-1.75],0.820205498186103,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TCTN3,Tectonic-3,Inverse variance weighted,33,0.98 [0.84-1.15],0.82101666569135,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,0.97 [0.75-1.26],0.822791147210086,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NRP2,Neuropilin-2,Inverse variance weighted,11,1.04 [0.76-1.42],0.824995808347043,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.99 [0.86-1.13],0.828286759802478,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,7,0.95 [0.6-1.51],0.829489453389661,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,1.01 [0.89-1.15],0.830533524407566,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.97 [0.71-1.32],0.830976029453824,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,0.99 [0.86-1.13],0.831399555434558,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",Inverse variance weighted,2,1.12 [0.41-3.07],0.831495311086819,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THOP1,Thimet oligopeptidase,Inverse variance weighted,5,0.97 [0.71-1.33],0.837487404188535,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,0.93 [0.44-1.94],0.838751637521855,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TIE1,Tyrosine-protein kinase receptor Tie-1,Inverse variance weighted,2,1.07 [0.56-2.04],0.840461764398752,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.03 [0.75-1.42],0.841675078424104,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,1.03 [0.75-1.41],0.847700990392512,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,1.23 [0.14-10.59],0.85206486280034,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,0.9 [0.31-2.64],0.853395085560666,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.03 [0.73-1.47],0.854010100843987,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,1.04 [0.66-1.66],0.85691026807316,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TEK,Angiopoietin-1 receptor,Inverse variance weighted,13,1.02 [0.8-1.31],0.859275844044539,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.97 [0.7-1.35],0.859603737052243,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.23 [0.12-12.27],0.859777394102747,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,Inverse variance weighted,11,0.97 [0.71-1.33],0.86361487638101,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,1.04 [0.69-1.55],0.866076288035299,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,32,1.01 [0.86-1.2],0.866157739736491,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NECTIN2,Nectin-2,Inverse variance weighted,5,0.98 [0.76-1.27],0.871592469522218,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.08 [0.39-3.04],0.879538514728159,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.03 [0.69-1.55],0.880794069186424,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.93 [0.38-2.31],0.881966212030775,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KITLG,Kit ligand,Wald ratio,1,0.88 [0.15-4.99],0.881987824477534,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,1.16 [0.16-8.36],0.882834383274288,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,0.99 [0.86-1.13],0.888907339629852,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPON1,Spondin-1,Inverse variance weighted,21,0.98 [0.79-1.23],0.893414423960491,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LMNB2,Lamin-B2,Wald ratio,1,1.16 [0.13-10.09],0.893416321305544,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCN2,Ficolin-2,Inverse variance weighted,25,0.99 [0.83-1.17],0.895742486497592,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH6,Cadherin-6,Inverse variance weighted,29,1.01 [0.86-1.19],0.896127477125298,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.02 [0.74-1.4],0.897345666574754,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPP1,Osteopontin,Inverse variance weighted,8,0.96 [0.53-1.76],0.899772125163186,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.01 [0.88-1.16],0.902678154665908,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CREG1,Protein CREG1,Inverse variance weighted,3,0.97 [0.59-1.59],0.905568892720575,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.98 [0.66-1.44],0.907013804767424,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.99 [0.85-1.15],0.907856975452367,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.01 [0.9-1.12],0.910201116816895,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,0.97 [0.54-1.73],0.910258375173681,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,0.99 [0.89-1.11],0.915280009515014,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.99 [0.85-1.16],0.915813079188616,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,0.98 [0.67-1.43],0.917379665769442,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,Inverse variance weighted,46,1 [0.92-1.1],0.917586740437069,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,2,1.12 [0.12-10.29],0.917917846415449,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.02 [0.69-1.5],0.923854515792477,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,8,1.01 [0.79-1.29],0.924971338549515,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BMP6,Bone morphogenetic protein 6,Inverse variance weighted,3,1.06 [0.33-3.35],0.925116290513771,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,12,1.03 [0.58-1.81],0.9299278240685,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KHK,Ketohexokinase,Inverse variance weighted,22,0.99 [0.81-1.21],0.933091673657101,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,1.01 [0.84-1.2],0.934496309089641,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.99 [0.81-1.22],0.935497979790787,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD248,Endosialin,Inverse variance weighted,2,1.07 [0.18-6.34],0.936956450053949,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,0.99 [0.81-1.21],0.93733917359765,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,7,1.01 [0.73-1.41],0.940333879070569,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,0.99 [0.87-1.14],0.940375639906878,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,4,0.98 [0.56-1.71],0.944302044246382,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLAT,Tissue-type plasminogen activator,Wald ratio,1,1.06 [0.19-5.81],0.944741885946183,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C19orf12,Protein C19orf12,Wald ratio,1,1.08 [0.1-11.2],0.946197477309821,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,1 [0.91-1.1],0.948370455281913,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DCXR,L-xylulose reductase,Inverse variance weighted,2,0.98 [0.59-1.64],0.948552015860061,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.04 [0.3-3.56],0.952726209503133,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1 [0.87-1.16],0.95436704171541,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HMOX2,Heme oxygenase 2,Inverse variance weighted,2,0.96 [0.23-3.95],0.955078087705367,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDHR2,Cadherin-related family member 2,Inverse variance weighted,2,1.02 [0.45-2.35],0.957425968656481,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.99 [0.75-1.31],0.958168604472707,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KEL,Kell blood group glycoprotein,Inverse variance weighted,9,0.99 [0.65-1.5],0.96152396842415,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,1.01 [0.71-1.43],0.962550144955188,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,0.99 [0.76-1.3],0.964549360487,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD5L,CD5 antigen-like,Inverse variance weighted,10,0.99 [0.71-1.4],0.968180022844692,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,1.01 [0.73-1.38],0.969955780577976,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.02 [0.3-3.53],0.970492246162568,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHRDL2,Chordin-like protein 2,Inverse variance weighted,7,0.99 [0.66-1.5],0.970761957796027,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,1.01 [0.65-1.57],0.971067405938502,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PGF,Placenta growth factor,Inverse variance weighted,2,1.04 [0.11-10.09],0.971409078176875,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VTCN1,V-set domain-containing T-cell activation inhibitor 1,Wald ratio,1,0.98 [0.24-3.97],0.972999548623034,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,1 [0.79-1.26],0.973137361039944,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,10,1 [0.82-1.23],0.973424287086933,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD109,CD109 antigen,Inverse variance weighted,45,1 [0.9-1.11],0.977926167469035,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MME,Neprilysin,Inverse variance weighted,3,1 [0.34-2.92],0.994568048677278,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BSG,Basigin,Wald ratio,1,1 [0.53-1.9],0.995017788973734,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1 [0.84-1.19],0.997650298237886,cis
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GSTA1,Glutathione S-transferase A1,Wald ratio,1,99.83 [15.62-637.9],1.14500616636394e-06,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,5.39 [2.26-12.87],0.000150083171456891,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRC,Receptor-type tyrosine-protein phosphatase C,Inverse variance weighted,8,2.74 [1.56-4.82],0.000476863067167408,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,22,1.49 [1.18-1.88],0.00072432216544346,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,0.34 [0.15-0.78],0.0100116698606584,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,3.42 [1.33-8.76],0.0104241176176258,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,15,0.6 [0.39-0.9],0.01486895604982,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DDC,Aromatic-L-amino-acid decarboxylase,Inverse variance weighted,6,3.23 [1.26-8.32],0.0149285888636614,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,2.79 [1.21-6.43],0.0158918915275303,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.69 [1.1-2.6],0.0174356880025182,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FUOM,Fucose mutarotase,Inverse variance weighted,6,2.29 [1.16-4.54],0.0176372269620718,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,Inverse variance weighted,11,0.59 [0.37-0.92],0.0200199761981603,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.68 [1.08-2.61],0.0205153824919862,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.61 [0.39-0.93],0.0236292520505157,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRSS8,Prostasin,Inverse variance weighted,14,0.62 [0.41-0.94],0.0252093701593778,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,2.57 [1.12-5.89],0.0263435245896552,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,2.09 [1.08-4.03],0.0277449823156913,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,0.64 [0.43-0.96],0.0302285680664604,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSS,Cathepsin S,Inverse variance weighted,7,0.42 [0.19-0.92],0.0308703774916475,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.42 [0.19-0.93],0.0316197685993024,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GDF15,Growth/differentiation factor 15,Wald ratio,1,16.65 [1.24-223.18],0.0336587175429583,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PON2,Serum paraoxonase/arylesterase 2,Inverse variance weighted,22,0.79 [0.63-0.98],0.0351968223275839,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,3.58 [1.09-11.79],0.0359813324462159,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDHR2,Cadherin-related family member 2,Inverse variance weighted,13,2.5 [1.06-5.91],0.0371722102442079,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SHISA5,Protein shisa-5,Inverse variance weighted,12,2.34 [1.05-5.23],0.0382414193624438,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,5.6 [1.08-29.08],0.0403766494875893,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PALM2,Paralemmin-2,Inverse variance weighted,9,0.67 [0.46-0.99],0.0416491307472456,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,2.31 [1.02-5.22],0.0442879017620134,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRUNE2,Protein prune homolog 2,Wald ratio,1,8.93 [1.05-75.87],0.0448339443286858,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.34 [0.12-0.98],0.0459981072047363,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,1.37 [1-1.87],0.0466550335915237,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD276,CD276 antigen,Inverse variance weighted,24,0.75 [0.56-1],0.0500065997181452,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.84 [1-3.38],0.0514275282987534,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.29 [0.99-1.68],0.0578436830205982,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Inverse variance weighted,16,4.64 [0.93-23.13],0.0608788229008759,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGALS4,Galectin-4,Inverse variance weighted,15,0.81 [0.65-1.01],0.0609295026357667,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SERPINA9,Serpin A9,Wald ratio,1,0.12 [0.01-1.11],0.0617525486633742,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.45 [0.2-1.04],0.0621267843449299,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LMNB2,Lamin-B2,Inverse variance weighted,8,0.54 [0.28-1.04],0.064798567557759,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,24,1.28 [0.98-1.65],0.0672507212235055,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCRL5,Fc receptor-like protein 5,Inverse variance weighted,23,1.38 [0.97-1.97],0.070409687632821,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MVK,Mevalonate kinase,Wald ratio,1,0.02 [0-1.44],0.0716034989322284,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.62 [0.95-2.76],0.0757037546981327,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCRL1,Fc receptor-like protein 1,Inverse variance weighted,32,0.77 [0.58-1.03],0.0771064486291558,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.38 [0.96-1.96],0.0779799214162452,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PGF,Placenta growth factor,Inverse variance weighted,5,1.87 [0.93-3.75],0.0793272335223948,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SGSH,N-sulphoglucosamine sulphohydrolase,Inverse variance weighted,49,1.11 [0.99-1.26],0.0795362049372294,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,1.27 [0.97-1.65],0.0812707644006361,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,1.54 [0.95-2.49],0.0815873381696583,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSD,Cathepsin D,Inverse variance weighted,7,0.54 [0.27-1.08],0.0830778036611399,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.18 [0.02-1.27],0.0856874800312299,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.74 [0.93-3.27],0.0857449056935295,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLUL1,Clusterin-like protein 1,Inverse variance weighted,7,2.08 [0.9-4.83],0.0883840236490432,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.21 [0.03-1.27],0.0885524892066127,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,2.41 [0.88-6.63],0.0885591602682316,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.87 [0.73-1.02],0.0924641114585259,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.6 [0.33-1.09],0.0927994047515555,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NRP2,Neuropilin-2,Inverse variance weighted,14,1.52 [0.93-2.48],0.0944295474991587,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.29 [0.95-1.74],0.0991292250809863,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C19orf12,Protein C19orf12,Inverse variance weighted,3,2.1 [0.87-5.1],0.100090960943823,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GRN,Progranulin,Inverse variance weighted,46,1.14 [0.98-1.33],0.100333585173061,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VWF,von Willebrand factor,Inverse variance weighted,6,0.61 [0.33-1.1],0.100960172601903,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.77 [0.56-1.06],0.106270665415878,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOMO1,Nodal modulator 1,Inverse variance weighted,24,1.14 [0.97-1.34],0.108591113228632,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,Inverse variance weighted,13,0.66 [0.39-1.11],0.115622462579139,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,11,0.61 [0.32-1.14],0.118112785590819,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,5.98 [0.61-58.54],0.124137633572692,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CNTN4,Contactin-4,Inverse variance weighted,12,0.64 [0.36-1.14],0.128016826339167,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPQ,Carboxypeptidase Q,Inverse variance weighted,53,0.9 [0.78-1.03],0.12890131688798,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGSF9,Protein turtle homolog A,Inverse variance weighted,2,0.37 [0.1-1.34],0.131294396698116,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,654.94 [0.14-3044443.76],0.13229197301416,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.28 [0.93-1.76],0.134127571334393,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.44 [0.89-2.32],0.135716374938098,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.61 [0.85-3.03],0.141129144536199,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,37,0.79 [0.58-1.08],0.143846175539992,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DPP10,Inactive dipeptidyl peptidase 10,Inverse variance weighted,24,1.19 [0.94-1.51],0.146391137682189,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VSIG10,V-set and immunoglobulin domain-containing protein 10,Wald ratio,1,0.21 [0.03-1.73],0.148003651707496,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD244,Natural killer cell receptor 2B4,Inverse variance weighted,18,1.31 [0.91-1.91],0.151278756449663,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NRP1,Neuropilin-1,Inverse variance weighted,14,1.56 [0.85-2.85],0.151721298847164,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ARSA,Arylsulfatase A,Inverse variance weighted,7,0.79 [0.57-1.09],0.153083479065781,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.17 [0.94-1.47],0.157111948096382,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DIPK2B,Divergent protein kinase domain 2B,Inverse variance weighted,9,0.6 [0.3-1.22],0.157268042631539,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.18 [0.94-1.47],0.159022689202265,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PKD1,Polycystin-1,Inverse variance weighted,12,0.65 [0.35-1.2],0.166063763692024,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.48 [0.17-1.35],0.16648046518185,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.3 [0.9-1.88],0.166587356012378,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,4.98 [0.51-48.84],0.168355838154538,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHRDL2,Chordin-like protein 2,Inverse variance weighted,9,1.56 [0.83-2.93],0.170881623503331,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.36 [0.88-2.11],0.171686219748135,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.24 [0.03-1.86],0.173389685745186,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,11,1.29 [0.89-1.86],0.175008156956281,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAMP2,Lysosome-associated membrane glycoprotein 2,Inverse variance weighted,6,1.85 [0.76-4.53],0.175824284663112,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1.55 [0.82-2.93],0.178667508368146,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RNASE6,Ribonuclease K6,Inverse variance weighted,4,2.19 [0.7-6.85],0.179962491911405,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.33 [0.87-2.03],0.180992162867599,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.2 [0.92-1.56],0.186767224716871,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NELL2,Protein kinase C-binding protein NELL2,Inverse variance weighted,26,0.78 [0.54-1.13],0.18936690336081,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,3.47 [0.54-22.27],0.189588415137528,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.77 [0.53-1.14],0.190882278745863,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALCAM,CD166 antigen,Inverse variance weighted,4,0.68 [0.38-1.21],0.191334445074755,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.58 [0.25-1.32],0.191401800165731,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,0.6 [0.28-1.29],0.191596798854709,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,1.49 [0.82-2.7],0.192280482523663,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,OCLN,Occludin,Inverse variance weighted,2,2.27 [0.66-7.83],0.196167963488683,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KHK,Ketohexokinase,Inverse variance weighted,4,0.5 [0.18-1.43],0.198059834746717,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CR2,Complement receptor type 2,Inverse variance weighted,36,1.2 [0.91-1.58],0.198568877526295,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AREG,Amphiregulin,Inverse variance weighted,5,1.79 [0.73-4.35],0.200562305306671,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,0.63 [0.31-1.28],0.200595498536604,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,0.87 [0.71-1.08],0.201151701262252,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",Inverse variance weighted,7,1.47 [0.81-2.69],0.205922037344887,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1.29 [0.87-1.9],0.209343177385783,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.43 [0.82-2.48],0.210842912298849,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.7 [0.4-1.23],0.211203040827301,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,1.08 [0.96-1.22],0.214508023087562,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NME3,Nucleoside diphosphate kinase 3,Inverse variance weighted,11,0.78 [0.53-1.16],0.218036883717809,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM2,Intercellular adhesion molecule 2,Inverse variance weighted,79,1.07 [0.96-1.19],0.223753501611891,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DCXR,L-xylulose reductase,Inverse variance weighted,9,1.39 [0.82-2.36],0.227344283761004,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.26 [0.03-2.36],0.230264588289095,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KEL,Kell blood group glycoprotein,Inverse variance weighted,37,1.14 [0.92-1.42],0.231211604984636,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,1.08 [0.95-1.21],0.231501528318242,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VNN2,Vascular non-inflammatory molecule 2,Inverse variance weighted,10,1.42 [0.8-2.52],0.232733958152763,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,0.62 [0.29-1.36],0.232879487698744,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,Inverse variance weighted,4,0.36 [0.07-1.94],0.233721869317264,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DPP6,Dipeptidyl aminopeptidase-like protein 6,Inverse variance weighted,10,0.71 [0.41-1.24],0.23412442949264,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,0.72 [0.41-1.24],0.235305203617899,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,Inverse variance weighted,3,0.23 [0.02-2.58],0.235490215876502,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GUSB,Beta-glucuronidase,Inverse variance weighted,31,1.34 [0.82-2.19],0.236662301567834,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,1.32 [0.83-2.08],0.236771093144062,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,0.91 [0.77-1.07],0.239512974140165,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADA,Adenosine deaminase,Inverse variance weighted,22,0.92 [0.8-1.06],0.241221606570425,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC9,Sialic acid-binding Ig-like lectin 9,Inverse variance weighted,67,1.08 [0.95-1.24],0.241691544156783,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.18 [0.89-1.56],0.243928405764295,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KCTD5,BTB/POZ domain-containing protein KCTD5,Inverse variance weighted,5,2.47 [0.54-11.29],0.243942074590477,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.11 [0.93-1.33],0.247172906630799,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,7,1.3 [0.83-2.03],0.24784018166224,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,0.82 [0.58-1.15],0.249530355630008,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD22,B-cell receptor CD22,Inverse variance weighted,25,0.81 [0.56-1.16],0.251308013769375,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FLT3LG,Fms-related tyrosine kinase 3 ligand,Inverse variance weighted,50,1.18 [0.89-1.57],0.252483875238802,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.33 [0.82-2.15],0.25281189353609,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.49 [0.75-2.97],0.253555429690709,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.55 [0.72-3.35],0.262142140795977,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.42 [0.09-1.9],0.262887633587564,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,1.55 [0.72-3.37],0.264251753126587,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRM,Receptor-type tyrosine-protein phosphatase mu,Inverse variance weighted,22,0.82 [0.58-1.16],0.265522848313074,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.74 [0.43-1.27],0.266794075997766,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDK2,Protein sidekick-2,Inverse variance weighted,22,1.1 [0.93-1.31],0.27160435478738,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,0.76 [0.47-1.24],0.272931508219955,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,1.04 [0.97-1.13],0.273078431438924,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.18 [0.88-1.59],0.274789468039549,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.79 [0.63-5.08],0.277324944010917,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDGFRB,Platelet-derived growth factor receptor beta,Inverse variance weighted,7,0.7 [0.36-1.34],0.277797742549004,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPON1,Spondin-1,Inverse variance weighted,4,1.65 [0.67-4.06],0.277953429941392,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.73 [0.42-1.29],0.284278911119145,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.17 [0.01-4.4],0.284340174671141,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,1.59 [0.68-3.69],0.284988346403511,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.3 [0.8-2.11],0.287167205634128,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CFC1,Cryptic protein,Inverse variance weighted,11,1.34 [0.78-2.32],0.28975808311631,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF6,SLAM family member 6,Inverse variance weighted,2,0.46 [0.11-1.92],0.29002963050886,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.83 [0.59-1.17],0.291625690974622,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.79 [0.5-1.23],0.291653991617821,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.72 [0.39-1.33],0.292006216632349,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,17,1.24 [0.83-1.88],0.297134829391499,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SUOX,"Sulfite oxidase, mitochondrial",Inverse variance weighted,8,0.82 [0.57-1.19],0.299625868224027,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.9 [0.74-1.1],0.301915094151048,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LY75,Lymphocyte antigen 75,Inverse variance weighted,35,1.27 [0.8-2.01],0.306044944694625,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.58 [0.2-1.66],0.306102293453905,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.48 [0.7-3.13],0.308010835482836,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.74 [0.42-1.32],0.310228850125353,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.86 [0.64-1.15],0.310318338921217,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCP2,Non-specific lipid-transfer protein,Wald ratio,1,4.95 [0.22-109.1],0.310585406753593,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.71 [0.6-4.84],0.311612934380854,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ERBB4,Receptor tyrosine-protein kinase erbB-4,Inverse variance weighted,15,0.77 [0.46-1.28],0.311829361376433,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.51 [0.14-1.88],0.313218189230097,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,11,1.36 [0.75-2.47],0.315668851863044,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSC,Dipeptidyl peptidase 1,Inverse variance weighted,12,0.79 [0.51-1.24],0.315784442782475,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,0.93 [0.8-1.07],0.316605689496633,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BOC,Brother of CDO,Inverse variance weighted,8,1.34 [0.75-2.37],0.319211832593721,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,0.34 [0.04-2.89],0.321566095962543,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,2.33 [0.43-12.54],0.32485271056377,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VCAN,Versican core protein,Inverse variance weighted,30,0.87 [0.67-1.14],0.327225666289903,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLEC11A,C-type lectin domain family 11 member A,Inverse variance weighted,14,0.81 [0.52-1.25],0.331296944120395,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,1.17 [0.85-1.61],0.331972527524961,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCN2,Ficolin-2,Inverse variance weighted,53,1.08 [0.92-1.28],0.334234564165678,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.75 [0.42-1.35],0.335022107538043,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.33 [0.74-2.39],0.336878498804149,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACHE,Acetylcholinesterase,Inverse variance weighted,18,0.87 [0.66-1.16],0.337588434950588,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,5,1.39 [0.71-2.74],0.340980571444304,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.92 [0.78-1.09],0.344955383317429,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.94 [0.81-1.07],0.345337308130677,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.79 [0.49-1.29],0.350748074919314,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.66 [0.28-1.57],0.35092256783131,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEZ6,Seizure protein 6 homolog,Inverse variance weighted,2,1.71 [0.55-5.33],0.352431975213013,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADH1B,All-trans-retinol dehydrogenase,Wald ratio,1,1.78 [0.52-6.08],0.354864388483103,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHGA,Chromogranin-A,Inverse variance weighted,5,0.62 [0.22-1.71],0.355177716251361,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGA5,Integrin alpha-5,Inverse variance weighted,18,0.84 [0.59-1.21],0.358946206468553,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.78 [0.46-1.33],0.360762981458162,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.75 [0.4-1.39],0.362216559276203,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,4.01 [0.2-80.02],0.362926068982052,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGB7,Integrin beta-7,Inverse variance weighted,42,1.2 [0.81-1.78],0.363993137576518,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.92 [0.76-1.11],0.366091305484759,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,0.86 [0.63-1.19],0.36972024952103,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.21 [0.79-1.85],0.371722414474292,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAYN,Layilin,Inverse variance weighted,3,0.54 [0.14-2.1],0.371741664870141,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ECE1,Endothelin-converting enzyme 1,Inverse variance weighted,3,1.75 [0.51-6.07],0.376871057603423,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD48,CD48 antigen,Inverse variance weighted,14,1.25 [0.76-2.05],0.38381611351781,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,UPB1,Beta-ureidopropionase,Wald ratio,1,10.84 [0.05-2386.62],0.386661142218095,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLSTN3,Calsyntenin-3,Inverse variance weighted,7,1.41 [0.65-3.08],0.387242958312659,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRE2,Adhesion G protein-coupled receptor E2,Inverse variance weighted,6,1.49 [0.6-3.69],0.391680710171791,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.15 [0.83-1.6],0.392258192779971,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.67 [0.27-1.67],0.393388852875001,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH2,Cadherin-2,Inverse variance weighted,21,1.25 [0.75-2.07],0.39362477743138,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.45 [0.62-3.42],0.394564948151883,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.76 [0.41-1.43],0.400605852840881,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,0.81 [0.48-1.34],0.405556395811272,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.66 [0.25-1.76],0.410102577965722,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.16 [0.82-1.65],0.411981615174573,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,12,1.21 [0.77-1.89],0.413610366132077,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ASS1,Argininosuccinate synthase,Inverse variance weighted,2,1.68 [0.48-5.81],0.414276936012134,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.76 [0.39-1.48],0.415032973475228,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,15,0.8 [0.47-1.37],0.41747062121046,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD5L,CD5 antigen-like,Inverse variance weighted,44,1.12 [0.86-1.46],0.418082382019648,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD86,T-lymphocyte activation antigen CD86,Inverse variance weighted,17,0.87 [0.62-1.22],0.419859163631074,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MME,Neprilysin,Inverse variance weighted,46,1.08 [0.89-1.32],0.420669173919923,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACY1,Aminoacylase-1,Inverse variance weighted,6,1.27 [0.71-2.26],0.420724488693049,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.74 [0.36-1.54],0.422489765618597,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,1.1 [0.87-1.4],0.42463586851777,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.86 [0.6-1.24],0.424939155542628,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,Inverse variance weighted,18,1.16 [0.81-1.66],0.424993108255233,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,0.77 [0.4-1.48],0.427900630153472,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LEPR,Leptin receptor,Inverse variance weighted,3,0.66 [0.23-1.86],0.42849669734078,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.07 [0.91-1.25],0.430780854138499,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,Inverse variance weighted,33,1.07 [0.9-1.27],0.431957667588404,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.3 [0.67-2.49],0.435420430416822,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KYNU,Kynureninase,Inverse variance weighted,3,1.78 [0.42-7.57],0.435582606417702,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BSG,Basigin,Inverse variance weighted,6,0.74 [0.34-1.59],0.437103111597171,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,Inverse variance weighted,18,1.23 [0.73-2.05],0.437135114054031,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,0.75 [0.37-1.55],0.43873897681855,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.14 [0.82-1.58],0.440966320775415,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDH12,Protocadherin-12,Inverse variance weighted,6,1.21 [0.74-1.96],0.441651089823092,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NECTIN2,Nectin-2,Inverse variance weighted,3,0.57 [0.14-2.39],0.445209921259689,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.64 [0.46-5.81],0.445381365561864,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.2 [0.75-1.92],0.448739378502315,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.27 [0.69-2.33],0.449764716533704,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRE1,Adhesion G protein-coupled receptor E1,Inverse variance weighted,22,0.88 [0.64-1.22],0.451867966067429,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.2 [0.74-1.96],0.45224962375581,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH1,Cadherin-1,Inverse variance weighted,16,1.14 [0.81-1.6],0.454356300129773,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGB2,Integrin beta-2,Inverse variance weighted,20,0.89 [0.65-1.21],0.454979038786912,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.15 [0.8-1.65],0.459448168601567,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SHBG,Sex hormone-binding globulin,Inverse variance weighted,11,1.25 [0.69-2.3],0.462966115037053,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,0.82 [0.49-1.39],0.465044498879148,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.85 [0.55-1.32],0.466549385791993,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ISM1,Isthmin-1,Inverse variance weighted,2,0.45 [0.05-3.96],0.469646913032083,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PVR,Poliovirus receptor,Inverse variance weighted,3,0.64 [0.18-2.18],0.471309096575948,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.34 [0.6-3.02],0.474577537066725,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1.15 [0.79-1.67],0.475524257647914,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.21 [0.72-2.02],0.476310065382121,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENTR1,Endosome-associated-trafficking regulator 1,Inverse variance weighted,8,1.21 [0.72-2.04],0.476919287191905,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH5,Cadherin-5,Inverse variance weighted,23,0.95 [0.83-1.09],0.47782663646708,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.1 [0.84-1.46],0.480401585856685,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CREG1,Protein CREG1,Inverse variance weighted,20,1.09 [0.85-1.41],0.48041732262841,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,0.8 [0.44-1.48],0.484489230121512,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGB1,Integrin beta-1,Inverse variance weighted,5,1.25 [0.66-2.36],0.4858145641963,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MUC13,Mucin-13,Inverse variance weighted,3,0.65 [0.19-2.18],0.485985847524307,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.17 [0.75-1.82],0.486073219376886,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GSTA3,Glutathione S-transferase A3,Inverse variance weighted,2,8.01 [0.02-2800.44],0.486325593369182,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,0.73 [0.29-1.8],0.4885217348484,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,1.43 [0.52-3.93],0.489650052920744,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL32,Interleukin-32,Inverse variance weighted,9,0.84 [0.5-1.4],0.496799590210562,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH6,Cadherin-6,Inverse variance weighted,5,0.74 [0.3-1.8],0.502725442773062,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.83 [0.48-1.44],0.504754122845668,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,UXS1,UDP-glucuronic acid decarboxylase 1,Inverse variance weighted,7,0.84 [0.51-1.4],0.505817246639797,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PSAP,Prosaposin,Inverse variance weighted,13,0.91 [0.68-1.21],0.506535784595753,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TLR3,Toll-like receptor 3,Inverse variance weighted,9,0.89 [0.64-1.25],0.507041393011149,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.22 [0.67-2.23],0.507920146568655,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.15 [0.76-1.74],0.512163480518668,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGMN,Legumain,Inverse variance weighted,22,0.88 [0.6-1.29],0.512198877388824,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DSCAM,Down syndrome cell adhesion molecule,Inverse variance weighted,24,0.95 [0.82-1.1],0.513330783312362,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.07 [0.87-1.31],0.519328415972938,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.09 [0.84-1.41],0.520116892285657,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.93 [0.74-1.16],0.520522698126042,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FRZB,Secreted frizzled-related protein 3,Inverse variance weighted,14,0.89 [0.63-1.27],0.521316035285293,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.12 [0.79-1.6],0.523859077146549,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,Wald ratio,1,1.93 [0.26-14.59],0.524481582875144,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPP1,Osteopontin,Inverse variance weighted,13,0.84 [0.49-1.44],0.525646346409857,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.12 [0.79-1.59],0.527111486340689,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL6,Interleukin-6,Inverse variance weighted,6,1.13 [0.77-1.65],0.535043252707673,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,0.79 [0.37-1.69],0.53614426340172,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.88 [0.57-1.34],0.536429011713849,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TCOF1,Treacle protein,Wald ratio,1,1.9 [0.24-14.95],0.542946293734652,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.43 [0.45-4.56],0.544578898737348,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SELE,E-selectin,Inverse variance weighted,20,0.95 [0.81-1.12],0.545353450614627,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.24 [0.61-2.53],0.545836921845871,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.28 [0.57-2.87],0.5475990373974,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.13 [0.75-1.7],0.550280133289326,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEZ6L,Seizure 6-like protein,Inverse variance weighted,10,0.81 [0.4-1.65],0.555014953722111,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,0.81 [0.4-1.64],0.555216773063686,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.42 [0.44-4.6],0.55611297646429,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.87 [0.54-1.4],0.557232969024549,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1.2 [0.65-2.23],0.562228237201629,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPTX1,Neuronal pentraxin-1,Inverse variance weighted,46,0.96 [0.83-1.11],0.562394548320827,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.57 [0.08-3.87],0.566736450995115,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSB,Cathepsin B,Inverse variance weighted,28,0.9 [0.62-1.29],0.566977177385062,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ERBB2,Receptor tyrosine-protein kinase erbB-2,Inverse variance weighted,20,0.92 [0.71-1.21],0.567118156767895,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FTCD,Formimidoyltransferase-cyclodeaminase,Inverse variance weighted,6,0.82 [0.41-1.63],0.567557614348853,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.9 [0.61-1.31],0.567770508149597,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TCTN3,Tectonic-3,Inverse variance weighted,44,0.96 [0.82-1.12],0.569297924232934,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,0.73 [0.24-2.2],0.573040297212825,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HMOX2,Heme oxygenase 2,Inverse variance weighted,3,1.29 [0.53-3.13],0.576493197672905,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.05 [0.87-1.27],0.577822668976608,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,Inverse variance weighted,16,0.89 [0.59-1.34],0.578100593388245,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.07 [0.84-1.36],0.584074317303846,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,1.66 [0.27-10.31],0.586613802206744,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOTCH1,Neurogenic locus notch homolog protein 1,Inverse variance weighted,7,1.25 [0.55-2.85],0.5880002517674,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.95 [0.78-1.15],0.588112365912058,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALDH2,"Aldehyde dehydrogenase, mitochondrial",Inverse variance weighted,3,1.47 [0.36-5.93],0.588196238658783,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.92 [0.68-1.25],0.589325587174598,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,0.93 [0.72-1.21],0.592412010098106,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD27,CD27 antigen,Inverse variance weighted,9,1.25 [0.55-2.86],0.595381768006217,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CFHR5,Complement factor H-related protein 5,Inverse variance weighted,19,0.9 [0.61-1.33],0.59604860739577,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BMP6,Bone morphogenetic protein 6,Inverse variance weighted,13,0.88 [0.56-1.4],0.599647130364606,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.69 [0.17-2.8],0.600418437467344,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,0.89 [0.59-1.36],0.601873867766031,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RBKS,Ribokinase,Inverse variance weighted,5,0.79 [0.33-1.91],0.603395935609429,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CTSL,Cathepsin L1,Inverse variance weighted,29,0.92 [0.69-1.24],0.604734891867658,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.36 [0.42-4.45],0.607733232490636,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FBLN2,Fibulin-2,Inverse variance weighted,6,1.19 [0.61-2.3],0.608361941272385,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.42 [0.37-5.46],0.608656766436623,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.2 [0.59-2.47],0.61263066054434,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.51 [0.31-7.39],0.613729392799752,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,1.33 [0.43-4.16],0.619693946918349,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TGFBI,Transforming growth factor-beta-induced protein ig-h3,Inverse variance weighted,14,0.88 [0.54-1.44],0.620762596745591,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.9 [0.58-1.38],0.622135117570112,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.2 [0.58-2.48],0.623010952269763,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD83,CD83 antigen,Inverse variance weighted,14,0.89 [0.57-1.4],0.624846215350367,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,0.82 [0.36-1.84],0.626855627489084,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PEAR1,Platelet endothelial aggregation receptor 1,Inverse variance weighted,5,1.24 [0.51-3.02],0.62925048292714,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD109,CD109 antigen,Inverse variance weighted,36,1.05 [0.87-1.26],0.629838634014486,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CES1,Liver carboxylesterase 1,Inverse variance weighted,19,0.86 [0.46-1.6],0.630396038255846,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NOTCH2,Neurogenic locus notch homolog protein 2,Inverse variance weighted,14,0.95 [0.79-1.16],0.631528910582679,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,APOL1,Apolipoprotein L1,Inverse variance weighted,46,0.96 [0.81-1.13],0.63435372321593,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,0.9 [0.58-1.4],0.63499054250592,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ASAH1,Acid ceramidase,Inverse variance weighted,4,0.76 [0.25-2.34],0.639112277514851,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.86 [0.47-1.59],0.640569962586483,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.91 [0.61-1.35],0.646101798240915,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MILR1,Allergin-1,Inverse variance weighted,43,1.02 [0.92-1.13],0.647230425713175,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.86 [0.45-1.65],0.659905553132072,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.83 [0.35-1.93],0.661360136073592,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEMA4C,Semaphorin-4C,Inverse variance weighted,3,0.8 [0.29-2.22],0.668285502794033,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD55,Complement decay-accelerating factor,Inverse variance weighted,8,0.88 [0.47-1.63],0.67662165700099,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1.2 [0.5-2.87],0.67822131144626,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.26 [0.42-3.73],0.679674112740249,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITGAM,Integrin alpha-M,Inverse variance weighted,12,1.13 [0.63-2.01],0.682060930749619,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFNGR2,Interferon gamma receptor 2,Inverse variance weighted,34,1.02 [0.92-1.13],0.683737109095717,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.89 [0.52-1.54],0.685684829624943,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,0.96 [0.79-1.16],0.685902371945792,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,THBS4,Thrombospondin-4,Inverse variance weighted,11,1.12 [0.65-1.93],0.687650217450417,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.91 [0.59-1.41],0.689245149677788,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FBP1,"Fructose-1,6-bisphosphatase 1",Inverse variance weighted,11,0.95 [0.72-1.24],0.694711162343613,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.15 [0.57-2.29],0.696987577145499,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.91 [0.55-1.49],0.69761152262393,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,0.83 [0.32-2.13],0.698530648605724,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL18,Interleukin-18,Inverse variance weighted,26,0.95 [0.73-1.24],0.70048634358891,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.74 [0.17-3.36],0.701709182226015,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.89 [0.49-1.62],0.702707472056821,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NFASC,Neurofascin,Inverse variance weighted,6,1.18 [0.51-2.71],0.702951240658868,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.14 [0.57-2.28],0.70689602473469,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.97 [0.85-1.11],0.707159913925482,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,4,1.42 [0.23-8.8],0.708836796097973,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.09 [0.69-1.72],0.711428228875718,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PODXL,Podocalyxin,Inverse variance weighted,10,1.08 [0.73-1.6],0.712121659309479,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1.22 [0.42-3.6],0.712584354843227,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.8 [0.25-2.56],0.712668333133263,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TEK,Angiopoietin-1 receptor,Inverse variance weighted,13,1.04 [0.83-1.32],0.714649634840611,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SERPINA7,Thyroxine-binding globulin,Inverse variance weighted,5,0.75 [0.16-3.55],0.716293451039877,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MMP10,Stromelysin-2,Wald ratio,1,1.51 [0.16-14.04],0.716955614539961,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GBP1,Guanylate-binding protein 1,Inverse variance weighted,4,0.89 [0.49-1.64],0.718700103640574,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,0.91 [0.52-1.57],0.730760768953015,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADGRE5,Adhesion G protein-coupled receptor E5,Inverse variance weighted,8,0.88 [0.44-1.78],0.731439342638509,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANPEP,Aminopeptidase N,Inverse variance weighted,2,0.65 [0.05-8],0.734348760241588,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GGH,Gamma-glutamyl hydrolase,Inverse variance weighted,26,0.94 [0.68-1.32],0.738016192044776,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,Inverse variance weighted,26,0.95 [0.71-1.27],0.739469944168426,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.83 [0.28-2.49],0.741374549435835,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCER2,Low affinity immunoglobulin epsilon Fc receptor,Inverse variance weighted,29,0.94 [0.64-1.37],0.744633633848489,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,Inverse variance weighted,11,1.04 [0.83-1.29],0.748679874188705,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPHA4,Ephrin type-A receptor 4,Inverse variance weighted,5,0.82 [0.24-2.78],0.749839119570222,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDC1,Syndecan-1,Inverse variance weighted,12,0.92 [0.56-1.52],0.751852038532057,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MATN2,Matrilin-2,Inverse variance weighted,28,0.97 [0.83-1.14],0.752893561163281,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AMOT,Angiomotin,Inverse variance weighted,9,0.91 [0.5-1.67],0.756771900553802,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,0.93 [0.59-1.46],0.757164713873614,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,INSR,Insulin receptor,Inverse variance weighted,5,1.13 [0.52-2.43],0.757494370297941,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.35 [0.2-9.4],0.758708514727746,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LGALS9,Galectin-9,Inverse variance weighted,36,0.97 [0.8-1.18],0.760136693901182,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.98 [0.88-1.1],0.76096037817575,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1.03 [0.86-1.23],0.761533964317622,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.11 [0.56-2.17],0.767982368015675,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ALDH1A1,Retinal dehydrogenase 1,Wald ratio,1,1.15 [0.45-2.95],0.768491840992482,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IFNLR1,Interferon lambda receptor 1,Wald ratio,1,0.79 [0.16-3.89],0.771329253601714,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.89 [0.41-1.95],0.772411344370386,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.82 [0.22-3.11],0.77260855645788,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.1 [0.56-2.17],0.777424565215216,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.97 [0.76-1.23],0.779537059096644,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.08 [0.63-1.85],0.779793443675723,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL8,Interleukin-8,Inverse variance weighted,8,0.94 [0.58-1.5],0.785626693845492,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,1.04 [0.76-1.43],0.78754438295099,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SPON2,Spondin-2,Inverse variance weighted,3,0.85 [0.26-2.8],0.787817088791198,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,Inverse variance weighted,8,0.9 [0.42-1.94],0.787894675826455,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,1.3 [0.19-8.92],0.789047110868337,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.88 [0.35-2.22],0.79438052648517,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.94 [0.58-1.51],0.795461649986603,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.78 [0.12-5.02],0.795573320296944,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CDH17,Cadherin-17,Inverse variance weighted,31,1.03 [0.85-1.24],0.796882658980123,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.94 [0.59-1.49],0.799944463191538,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.89 [0.34-2.32],0.806798366643622,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.78 [0.11-5.54],0.80818796191843,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.92 [0.44-1.89],0.812149071650114,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,Inverse variance weighted,14,0.92 [0.44-1.9],0.812252585304731,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.95 [0.63-1.43],0.813626168044147,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.02 [0.88-1.18],0.816547049502807,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IDUA,Alpha-L-iduronidase,Inverse variance weighted,18,1.07 [0.61-1.88],0.817226954375772,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.12 [0.43-2.89],0.818677879656866,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.03 [0.78-1.37],0.819946734173493,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.96 [0.65-1.4],0.823466516494328,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,Inverse variance weighted,12,0.94 [0.53-1.67],0.825473214054782,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,0.94 [0.56-1.58],0.82629093692624,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD248,Endosialin,Inverse variance weighted,17,1.05 [0.7-1.56],0.829772453897004,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MMP7,Matrilysin,Wald ratio,1,1.09 [0.49-2.45],0.830155121749837,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.98 [0.81-1.19],0.830221234669433,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,1.09 [0.5-2.35],0.831634964142733,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Inverse variance weighted,19,1.03 [0.77-1.38],0.832149796029527,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CALCA,Calcitonin,Inverse variance weighted,13,0.92 [0.45-1.91],0.832402319728757,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TYRO3,Tyrosine-protein kinase receptor TYRO3,Inverse variance weighted,20,0.96 [0.66-1.4],0.833052109358765,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.08 [0.54-2.16],0.833319356286101,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD8A,T-cell surface glycoprotein CD8 alpha chain,Inverse variance weighted,4,0.9 [0.33-2.44],0.833753229292904,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.93 [0.46-1.87],0.834624495193062,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.04 [0.72-1.51],0.837666223450457,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,Inverse variance weighted,2,1.16 [0.28-4.77],0.840592194439297,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CD302,CD302 antigen,Inverse variance weighted,11,1.05 [0.65-1.71],0.84243822426863,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.93 [0.44-1.98],0.85126457155461,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.03 [0.76-1.39],0.851694420814723,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.95 [0.57-1.6],0.854415317418929,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDC4,Syndecan-4,Inverse variance weighted,35,0.98 [0.76-1.25],0.854668577453669,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RNASET2,Ribonuclease T2,Inverse variance weighted,10,0.94 [0.49-1.79],0.8572117226086,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,1.03 [0.77-1.36],0.861796656385118,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AGRN,Agrin,Inverse variance weighted,14,1.04 [0.67-1.62],0.862021266917727,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.04 [0.67-1.6],0.866288172210867,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KITLG,Kit ligand,Inverse variance weighted,30,0.98 [0.73-1.31],0.868353914594718,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,1.05 [0.62-1.78],0.868461482591257,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.06 [0.55-2.04],0.871028048547527,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,1.03 [0.75-1.39],0.87208866494687,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,1.02 [0.84-1.22],0.872414511183954,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,2,1.12 [0.27-4.67],0.874910413020424,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.16 [0.18-7.33],0.875841395624946,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PTN,Pleiotrophin,Inverse variance weighted,3,0.88 [0.17-4.47],0.876255573139443,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.96 [0.54-1.68],0.876259058890955,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HEG1,Protein HEG homolog 1,Inverse variance weighted,14,0.96 [0.59-1.57],0.877257304099598,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.05 [0.56-1.95],0.879647432658576,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GZMA,Granzyme A,Inverse variance weighted,18,1.03 [0.68-1.56],0.88162033636319,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.08 [0.38-3.05],0.881802854481654,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,1.04 [0.65-1.65],0.883694810476695,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,STC1,Stanniocalcin-1,Inverse variance weighted,9,0.97 [0.64-1.46],0.887585061934961,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.96 [0.54-1.72],0.889693795766984,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CR1,Complement receptor type 1,Inverse variance weighted,15,1.03 [0.65-1.63],0.889784923047323,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,0.99 [0.79-1.23],0.893050225905773,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AKR7L,Aflatoxin B1 aldehyde reductase member 4,Wald ratio,1,0.92 [0.26-3.3],0.894147991124078,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.02 [0.75-1.38],0.898001586820835,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.05 [0.48-2.33],0.89968963211598,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.96 [0.52-1.77],0.90104966796414,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.08 [0.31-3.82],0.90434073803805,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.98 [0.68-1.42],0.908286356955001,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.96 [0.47-1.96],0.909918240497015,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1.02 [0.78-1.32],0.910524543733334,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SDHB,Succinate dehydrogenase,Inverse variance weighted,10,0.96 [0.47-1.98],0.910901283592978,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CPVL,Probable serine carboxypeptidase CPVL,Inverse variance weighted,19,0.98 [0.65-1.47],0.912831123525577,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,C7,Complement component C7,Inverse variance weighted,26,0.99 [0.8-1.23],0.916618841855529,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.04 [0.49-2.21],0.923083284188825,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,31,1.01 [0.77-1.33],0.927878326394974,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SORT1,Sortilin,Inverse variance weighted,11,0.98 [0.6-1.6],0.931413924388179,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,0.96 [0.42-2.23],0.931456549237942,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.98 [0.64-1.51],0.931947744787249,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.99 [0.75-1.3],0.93348486417367,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.03 [0.55-1.9],0.934770549462252,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,0.99 [0.84-1.18],0.935454852312237,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,Inverse variance weighted,33,0.99 [0.84-1.17],0.939611084466174,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,Inverse variance weighted,8,1.02 [0.55-1.9],0.940480645309008,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.05 [0.27-4.05],0.941123249305381,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.03 [0.49-2.17],0.941557462166831,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HMOX1,Heme oxygenase 1,Inverse variance weighted,20,1.01 [0.79-1.29],0.942368999536838,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,MARCO,Macrophage receptor MARCO,Inverse variance weighted,27,1.01 [0.73-1.4],0.942662628199126,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ENG,Endoglin,Inverse variance weighted,18,0.99 [0.84-1.18],0.944213149493461,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.03 [0.41-2.59],0.946659214437457,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,0.99 [0.77-1.28],0.947268680063698,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,0.98 [0.41-2.35],0.960993696878662,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TSPAN8,Tetraspanin-8,Inverse variance weighted,19,1.01 [0.68-1.5],0.96101366184021,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.97 [0.23-4.06],0.963113532085845,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PCDH9,Protocadherin-9,Inverse variance weighted,12,0.98 [0.52-1.88],0.963399564101119,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PRTG,Protogenin,Inverse variance weighted,8,1.02 [0.47-2.18],0.963759452871638,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TIE1,Tyrosine-protein kinase receptor Tie-1,Inverse variance weighted,18,1 [0.83-1.2],0.965572523433217,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,1.01 [0.64-1.6],0.969844072835158,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,NT5E,5'-nucleotidase,Inverse variance weighted,45,1 [0.79-1.27],0.973192759802652,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SLIT2,Slit homolog 2 protein,Wald ratio,1,1.03 [0.15-7.31],0.974179391870824,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1.01 [0.57-1.78],0.976384820294646,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ROBO2,Roundabout homolog 2,Inverse variance weighted,6,1.01 [0.57-1.79],0.977444496215724,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,Inverse variance weighted,2,1.02 [0.27-3.85],0.978733347429021,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.01 [0.64-1.58],0.979561619208278,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,XCL1,Lymphotactin,Inverse variance weighted,15,1.01 [0.6-1.7],0.980773630507929,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.01 [0.56-1.8],0.982645048162686,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.01 [0.38-2.67],0.98364968833153,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.99 [0.57-1.74],0.984667888177619,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,TLR1,Toll-like receptor 1,Wald ratio,1,0.98 [0.13-7.69],0.985345806137062,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,ICAM3,Intercellular adhesion molecule 3,Inverse variance weighted,22,1 [0.76-1.3],0.991033800648464,trans
Chapter IX Diseases of the circulatory system,I9_VARICVEOES,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1 [0.16-6.11],0.998725639970025,trans
